
AstraZeneca is retiring the MedImmune brand as part of a restructuring that will see biologics integrated into two new R&D …

Sanofi chief executive Olivier Brandicourt is considering sales or spin-offs of a number of the company’s divisions, as part of …

Lundbeck is cutting a thousand jobs globally as part of a restructuring programme to significantly lower its cost and focus …

Hundreds more jobs are at risk within GlaxoSmithKline as the fallout from the company’s asset-swapping deal with Novartis continues. Staff …

Merck & Co has said it intends to make additional reductions to its manufacturing network, although the pace of restructuring …

‘Challenging’ economic conditions in Europe are among the factors GlaxoSmithKline is blaming for its sluggish performance, with turnover worldwide down …

Sanofi is to cut 900 jobs in its French operations by 2015 – fewer than expected after widespread speculation this …

I have seen a lot in my healthcare career. Been round the block more than twice, as they say. I …

Merck KGaA has finalised the restructuring plans at Swiss drugs unit Merck Serono, confirming that it intends to close its …